A Bioequivalence Study Between Fluticasone Propionate 250 mcg and Salmeterol Xinafoate 50 mcg Inhalation Powder/Respirent Pharmaceuticals vs. ADVAIR DISKUS® 250/50 Inhalation Powder/GSK in Healthy Volunteers
Clinical trial NCT04746040 · UNKNOWN
Trial details
- NCT number
- NCT04746040
- Sponsor
- Respirent Pharmaceuticals Co Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-18
- Primary completion
- 2021-02-25
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.